eGenesis is a life sciences company focusing on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues and organs to the hundreds of thousands of patients worldwide who are in dire need.
Company (Alive / Active)
1 Kendall Square
Building 200, 2nd Floor, Suite 2203
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)